Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants

by van Oosten, L., Altenburg, J.J., Fougeroux, Cyrielle, Geertsema, C., van den End, E.J., Evers, W.A.C., Westphal, A.H., Lindhoud, S., van den Berg, W.A.M., Swarts, D.C., Deurhof, L., Suhrbier, Andreas, Le, Thuy T., Torres Morales, S., Myeni, S.K., Kikkert, Marjolein, Sander, Adam F., de Jongh, Willem Adriaan, Dagil, Robert, Nielsen, Morten A., Salanti, Ali, Søgaard, Max, Keijzer, T.M.P., Weijers, D., Eppink, M.H.M., Wijffels, R.H., van Oers, M.M., Martens, D.E., Pijlman, G.P.